Appili Therapeutics
Stock Forecast, Prediction & Price Target
Appili Therapeutics Financial Estimates
Appili Therapeutics Revenue Estimates
Appili Therapeutics EBITDA Estimates
Appili Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| CA$0 N/A | CA$1.39M 0% | CA$827.40K -40.50% | Avg: CA$542.96K Low: CA$542.96K High: CA$542.96K avg. -34.37% | |||
Net Income
% change YoY
| CA$-14.32M N/A | CA$-25.11M -75.34% | CA$-3.78M 84.94% | Avg: CA$-10.72M Low: CA$-6.54M High: CA$-6.54M avg. -183.58% | |||
EBITDA
% change YoY
| CA$-14.86M N/A | CA$-23.51M -58.13% | CA$-2.09M 91.08% | Avg: CA$-325.77K Low: CA$-325.77K High: CA$-325.77K avg. 84.46% | |||
EPS
% change YoY
| -$0.24 N/A | -$0.38 -58.33% | -$0.03 91.78% | Avg: -$0.05 Low: -$0.05 High: -$0.05 avg. -73.07% | |||
Operating Expenses
% change YoY
| CA$16.28M N/A | CA$24.94M 53.24% | CA$8.83M -64.58% | Avg: CA$4.10M Low: CA$4.10M High: CA$4.10M avg. -53.50% | |||
FAQ
What is Appili Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -183.58% in 2026-2026.
We have gathered data from 1 analysts. Their low estimate is -6.54M, average is -10.72M and high is -6.54M.
What is Appili Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -34.37% in 2026-2026.
We have gathered data from 1 analysts. Their low revenue estimate is CA$542.96K, average is CA$542.96K and high is CA$542.96K.
What is Appili Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -73.07% in 2026-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.05, average is -$0.05 and high is CA$-0.05.